James Hatton on licensing: Targacept/AstraZeneca Collaborative Research and License Agreement

<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener("load", function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <iframe src="http://www.blogger.com/navbar.g?targetBlogID=6223270&blogName=James+Hatton+on+licensing&publishMode=PUBLISH_MODE_FTP&navbarType=BLUE&layoutType=CLASSIC&searchRoot=http%3A%2F%2Fblogsearch.google.com%2F&blogLocale=en_CA&homepageUrl=http%3A%2F%2Fwww.jameshatton.com%2Fpublic%2F" marginwidth="0" marginheight="0" scrolling="no" frameborder="0" height="30px" width="100%" id="navbar-iframe" allowtransparency="true" title="Blogger Navigation and Search"></iframe> <div></div>

Monday, January 23, 2006

Targacept/AstraZeneca Collaborative Research and License Agreement

Full text of the Targacept/AstraZeneca Collaborative Research and License Agreement of December 27, 2005.

0 Comments:

Links to this post:

<$BlogBacklinkTitle$>: <$BlogBacklinkSnippet$>
posted by <$BlogBacklinkAuthor$> @ <$BlogBacklinkDateTime$>

Create a Link

<< Home

: Name: James Hatton; Location: Vancouver, British Columbia, Canada

I am a partner in Vancouver-based Farris, Vaughan, Wills & Murphy LLP. I focus my practice on assisting companies to exploit the value of their intellectual property assets, with a special interest in licensing and related transactions.

View my complete profile

James Hatton on licensing

Monday, January 23, 2006

Targacept/AstraZeneca Collaborative Research and License Agreement

0 Comments:

Links to this post:

About Me

Previous Posts